Latest Cancer News

Erivedge Approved for Basal Cell Skin Cancer (02-1-2012)
The US Food and Drug Administration (FDA) has approved the targeted therapy Erivedge™ (vismodegib) for the treatment basal cell carcinoma of the skin that has spread to other parts of the body or that... Continue Reading

Avastin May Improve Breast Cancer Response Rates (01-30-2012)
Among women with HER2-negative breast cancer that has not spread to distant sites in the body, the addition of Avastin to neoadjuvant (before-surgery) chemotherapy may increase the likelihood of a complete... Continue Reading

Drug May Delay Need for Prostate Cancer Treatment (01-26-2012)
Among men who choose active surveillance for early-stage prostate cancer, Avodart® (dutasteride) may delay cancer progression and the need for cancer treatment. These results were published in The Lancet. The... Continue Reading

More Cancer News

Locations

Radiation Oncology Center
One Presidential Blvd.
Suite 100
Bala Cynwyd, PA  19004
phone: 610-632-4100
fax: 610-668-1067

518415417_zSshP-MRapidArc
RapidArc™ is a technology that improves the consistency of the radiation dose while making treatment up to eight times faster. It allows the beam to irradiate the entire tumor rather than irradiating it in segments as with older technologies.